Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.

[1]  J. Wingard,et al.  First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  M. Flowers,et al.  Secondary treatment of acute graft-versus-host disease: a critical review. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  J. Scarisbrick,et al.  Diagnosis and management of acute graft‐versus‐host disease , 2012, British journal of haematology.

[4]  R. Porcher,et al.  Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  M. Horowitz,et al.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation. , 2012, Blood.

[6]  H. Greinix,et al.  Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  M. MacMillan,et al.  The best endpoint for acute GVHD treatment trials. , 2010, Blood.

[8]  R. Storb,et al.  Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. , 2009, Blood.

[9]  E. Gatza,et al.  Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. , 2008, Blood.

[10]  M. Albert,et al.  Assessing the potential role of photopheresis in hematopoietic stem cell transplant , 2006, Bone Marrow Transplantation.

[11]  H. Greinix,et al.  The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. , 2006, Haematologica.

[12]  J. Wagner,et al.  Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  H. Greinix,et al.  Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. , 2000, Blood.

[14]  G. Dini,et al.  Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. , 1998, Blood.

[15]  克也 平山,et al.  A prospective randomized trial , 1995 .

[16]  D. Weisdorf,et al.  PREDNISONE THERAPY FOR ACUTE GRAFT‐VERSUS-HOST DISEASE: SHORT‐VERSUS LONG‐TERM TREATMENT , 1993, Transplantation.

[17]  R. Storb,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. , 1990, Blood.

[18]  K. Sullivan,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. , 1990, Blood.

[19]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.

[20]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .